13 June 2019

Notice of Results
Analyst and Investor Briefing

Collagen Solutions plc (AIM: COS), the developer and manufacturer of biomaterials and regenerative medicines for the enhancement and extension of human life, announces that it will issue its audited full year results for the year ended 31 March 2019 on Tuesday 9 July 2019.

Analyst briefing

An analyst briefing will take place at the offices of Walbrook PR, 4 Lombard Street, London, EC3V 9HD at 9.30am on Tuesday 9 July 2019.

Investor briefing

The Company will also be hosting an afternoon presentation for investors on Tuesday 9 July 2019, where Jamal Rushdy, CEO, and Hilary Spence, CFO, will summarise the full year results and discuss:

  • The Company and its operations;
  • Underlying business trends;
  • Growth strategy;
  • The recent placing and open offer;
  • Outlook and key milestones.

This investor event will take place at the Copper Bar, upstairs at Balls Brothers, 6 Adams Court, Old Broad St, London, EC2N 1DX at 4.30pm for a 4.45pm start. This will be followed by drinks and canapes, and a chance to network.

If you would like to register for either the analyst or investor presentation, please contact Walbrook PR on 020 7933 8780 or email collagen@walbrookpr.com

 

Enquiries:

Collagen Solutions Plc Contact via Walbrook
Jamal Rushdy, CEO  
Hilary Spence, CFO  
   
Cenkos Securities Plc (Nominated Adviser and Broker) Tel: 0207 397 8900
Giles Balleny / Stephen Keys  
   
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Anna Dunphy Mob: 07876 741 001